MTX-211

CAS No. 1952236-05-3

MTX-211( MTX 211 )

Catalog No. M13055 CAS No. 1952236-05-3

A first-in-class, highly selective, dual inhibitor of PI3K and EGFR kinases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 180 In Stock
2MG 91 In Stock
5MG 170 In Stock
10MG 275 In Stock
25MG 464 In Stock
50MG 626 In Stock
100MG 830 In Stock
200MG 1135 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MTX-211
  • Note
    Research use only, not for human use.
  • Brief Description
    A first-in-class, highly selective, dual inhibitor of PI3K and EGFR kinases.
  • Description
    A first-in-class, highly selective, dual inhibitor of PI3K and EGFR kinases with demonstrated in vivo anticancer activity against multiple KRAS mutant colorectal tumors; shows limited off-target toxicity and a broad therapeutic window.
  • In Vitro
    MTX-211 (MOL211) has inhibitory activity for both EGFR and PI3K Alpha with IC50 values of <100 nM.
  • In Vivo
    ——
  • Synonyms
    MTX 211
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    EGFR|PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1952236-05-3
  • Formula Weight
    478.323
  • Molecular Formula
    C20H14Cl2FN5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥100 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    CS(=O)(NC1=CC(C2=CC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=C2)=CN=C1Cl)=O
  • Chemical Name
    Methanesulfonamide, N-[2-chloro-5-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-3-pyridinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AMG 511

    AMG 511 is a potent and orally available pan inhibitor of class I PI3Ks(Kis of 4 nM, 6 nM, 2 nM and 1 nM for PI3Kα, β, δ and γ, respectively).

  • Wortmannin

    A potent PI3K inhibitor with IC50 3 nM, does not inhibit PI4K activity.

  • Idelalisib

    Idelalisib (CAL-101, GS-1101) is a potent, selective inhibitor of PI3K p110δ with IC50 of 2.5 nM.